MOREPENLABNSEMorepen Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Fri, 5 Jun · 17:46 IST

Dilesh Roadlines Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+11.0%1-day move
₹43.94
prior close
₹43.34
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+0.8+1.1+0.0+11.0+11.6+8.1+13.6+19.4+17.0+35.3+34.6
Up moveDown movePending
AI summary

Dilesh Roadlines Private Limited, likely a promoter-group entity, has submitted a disclosure to NSE under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation requires promoters and persons acting in concert to disclose details of encumbrance (such as pledges) on their shares. The headline does not specify whether the disclosure relates to creation, release, or invocation of a pledge, or the quantum of shares involved.

Likely market impact

This is a routine regulatory compliance filing and, on its own, is unlikely to have a meaningful impact on the stock price. Investors should look for the detailed disclosure to understand whether promoter shares have been pledged, released, or invoked, as this could indicate financial stress or easing of leverage at the promoter level.